iQure Pharma
PrivateLast Round
Series B
Jan 7, 2025
Total Funding Raised
$7M
Momentum Score
25 /100
Company Overview
iQure Pharma is a biotechnology company focused on developing innovative therapeutics for neurodegenerative diseases, including a novel chemical entity aimed at treating all types of epilepsy, particularly in drug-resistant patients, to provide new treatment options for physicians.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iQure Pharma Comps
Public and private peers based on sector, stage, and business model.
iQure Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 7, 2025 | ||||
| Series A | Oct 23, 2023 | ||||
| Series A | Aug 31, 2022 |
Key People
Founding team and executive leadership
iQure Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OKG Capital | Series A, Series B |
| i&i Biotech Fund I | Series B |
| Ventura BioMed Investors | Series A |
| i&i Biotech Fund | Series B |
| Ventura BioMedical | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2025
Prof. Dr. Iris Loew-Friedrich appointed as advisor.
iQure Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iQure Pharma's valuation, stock price, and market status.
